GLS2 is protumorigenic in breast cancers.
Dias MM, Adamoski D, Dos Reis LM, Ascencao CFR, de Oliveira KRS, Mafra ACP, da Silva Bastos AC, Quintero M, de G Cassago C, Ferreira IM, Fidelis CHV, Rocco SA, Bajgelman MC, Stine Z, Berindan-Neagoe I, Calin GA, Ambrosio ALB, Dias SMG
Oncogene. 2020 Jan;39(3):690-702. doi: 10.1038/s41388-019-1007-z. Epub 2019 Sep 20. PubMed Article
Dias MM, Adamoski D, Dos Reis LM, Ascencao CFR, de Oliveira KRS, Mafra ACP, da Silva Bastos AC, Quintero M, de G Cassago C, Ferreira IM, Fidelis CHV, Rocco SA, Bajgelman MC, Stine Z, Berindan-Neagoe I, Calin GA, Ambrosio ALB, Dias SMG
Oncogene. 2020 Jan;39(3):690-702. doi: 10.1038/s41388-019-1007-z. Epub 2019 Sep 20. PubMed Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 110333 | pQC hGAB.wt V5-His IRES G418 | Mammalian retroviral expression of glutaminase 2 isoform GAB (wild type) with V5 and 6xHis tags |
| 110335 | pLKO.puro_shGLS | shGLS (Target CAACTGGCCAAATTCAGTC), silence human GLS gene, puromycin selection |